Clinical Trials Browser

Phase 2 × budigalimab × 90 days × Clear all

NCT06119217 2026-05-13

Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients

Phase 2 Completed

194 enrolled 16 charts

Gastrointestinal

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms